Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hiroaki Miyanohara is active.

Publication


Featured researches published by Hiroaki Miyanohara.


Infection Control and Hospital Epidemiology | 2002

An epidemiologic survey of methicillin-resistant Staphylococcus aureus by combined use of mec-HVR genotyping and toxin genotyping in a university hospital in Japan.

Junichiro Nishi; Masao Yoshinaga; Hiroaki Miyanohara; Motoshi Kawahara; Masaharu Kawabata; Toshiro Motoya; Tetsuhiro Owaki; Shigeru Oiso; Masayuki Kawakami; Shigeko Kamewari; Yumiko Koyama; Naoko Wakimoto; Koichi Tokuda; Kunihiro Manago; Ikuro Maruyama

OBJECTIVE To evaluate the usefulness of an assay using two polymerase chain reaction-based genotyping methods in the practical surveillance of methicillin-resistant Staphylococcus aureus (MRSA). METHODS Nosocomial infection and colonization were surveyed monthly in a university hospital in Japan for 20 months. Genotyping with mec-HVR is based on the size of the mec-associated hypervariable region amplified by polymerase chain reaction. Toxin genotyping uses a multiplex polymerase chain reaction method to amplify eight staphylococcal toxin genes. RESULTS Eight hundred nine MRSA isolates were classified into 49 genotypes. We observed differing prevalences of genotypes for different hospital wards, and could rapidly demonstrate the similarity of genotype for outbreak isolates. The incidence of genotype D: SEC/TSST1 was significantly higher in isolates causing nosocomial infections (49.5%; 48 of 97) than in nasal isolates (31.4%; 54 of 172) (P = .004), suggesting that this genotype may represent the nosocomial strains. CONCLUSION The combined use of these two genotyping methods resulted in improved discriminatory ability and should be further investigated.


Pediatric Infectious Disease Journal | 2004

Relapsing cellulitis associated with Campylobacter coli bacteremia in an agammaglobulinemic patient.

Koichi Tokuda; Junichiro Nishi; Hiroaki Miyanohara; Jav Sarantuya; Mayumi Iwashita; Akira Kamenosono; Kazuko Hizukuri; Naoko Wakimoto; Masao Yoshinaga

Campylobacter coli rarely causes bacteremia or extraintestinal infection. We report herein a case of agammaglobulinemia in which cellulitis associated with C. coli bacteremia relapsed after a disease-free interval of >5 years. Pulsed field gel electrophoresis revealed that the organisms in this patient were genetically identical, suggesting a latent C. coli infection.


Fems Microbiology Letters | 2011

Environmental mutagens may be implicated in the emergence of drug-resistant microorganisms

Emiko Miyahara; Makiko Nishie; Shota Takumi; Hiroaki Miyanohara; Junichiro Nishi; Kiyotaka Yoshiie; Hiroshi Oda; Minoru Takeuchi; Masaharu Komatsu; Kohji Aoyama; Masahisa Horiuchi; Toru Takeuchi

The emergence of drug-resistant microorganisms is an important medical and social problem. Drug-resistant microorganisms are thought to grow selectively in the presence of antibiotics. Most clinically isolated drug-resistant microorganisms have mutations in the target genes for the drugs. While any of the many mutagens in the environment may cause such genetic mutations, no reports have yet described whether these mutagens can confer drug resistance to clinically important microorganisms. We investigated how environmental mutagens might be implicated in acquired resistance to antibiotics in clinically important microorganisms, which causes human diseases. We selected mutagens found in the environment, in cigarette smoke, or in drugs, and then exposed Pseudomonas aeruginosa to them. After exposure, the incidence of rifampicin- and ciprofloxacin-resistant P. aeruginosa strains markedly increased, and we found mutations in genes for the antibiotic-target molecule. These mutations were similar to those found in drug-resistant microorganisms isolated from clinical samples. Our findings show that environmental mutagens, and an anticancer drug, are capable of inducing drug-resistant P. aeruginosa similar to strains found in clinical settings.


International Journal of Antimicrobial Agents | 2009

Correlation between meropenem and doripenem use density and the incidence of carbapenem-resistant Pseudomonas aeruginosa

Akari Shigemi; Kazuaki Matsumoto; Keiko Yaji; Yoshihiro Shimodozono; Yasuo Takeda; Hiroaki Miyanohara; Hideki Kawamura; Michiyo Orita; Koichi Tokuda; Junichiro Nishi; Katsushi Yamada

Optimal use of carbapenems is an important issue in the prevention of resistance in Pseudomonas aeruginosa. In this study, we investigated the correlation between antimicrobial use density (AUD) of carbapenems and imipenem/cilastatin (IPM/CS) or meropenem (MEPM) susceptibility of P. aeruginosa strains. The AUD of five carbapenems [IPM/CS, panipenem/betamipron, biapenem, MEPM and doripenem (DRPM)] was examined every 6 months between 2006 and 2008. The AUD was calculated using the defined daily doses methodology developed by the World Health Organisation. A minimum inhibitory concentration of IPM/CS or MEPM of < or =4 mg/L was considered to be sensitive. There was a significant negative correlation between MEPM susceptibility and the total AUD of MEPM and DRPM [r=-0.823, 95% confidence interval (CI) -0.035 to -0.980; P=0.044]. Furthermore, there was a significant correlation between MEPM susceptibility and IPM/CS susceptibility (r=0.839, 95% CI 0.084 to 0.981; P=0.037). Cross-resistance was therefore investigated and only 5.6% of MEPM-insensitive strains were susceptible to IPM/CS, although 43.3% of IPM/CS-insensitive strains were susceptible to MEPM. These results suggest that curtailing the use of MEPM and DRPM may curb the emergence not only of MEPM-resistant strains but also IPM/CS-resistant strains.


Infection Control and Hospital Epidemiology | 1998

Difference in incidence and transmission mode of methicillin-resistant Staphylococcus aureus among surgery, orthopedics, and pediatrics wards : A prospective study at a University Hospital

Junichiro Nishi; Kazusada Shirao; Hiroshi Ito; Masao Yoshinaga; Heiji Yoshinaka; Hiroaki Miyanohara; Shingo Hirata; Hiroki Ogawa; Isao Kitajima; Ikuro Maruyama; Koichiro Miyata; Takashi Aiko; Takashi Sakou

The incidence and circumstances of colonization by methicillin-resistant Staphylococcus aureus were prospectively investigated. Among 404 patients, 15 (3.7%) were carriers on admission, and 43 (10.6%) became colonized, mainly after surgical operation. A different mode of transmission was suggested in each ward.


Pediatric Infectious Disease Journal | 2002

Characterization of Klebsiella pneumoniae and Escherichia coli strains that produce CTX-M-2-type broad spectrum beta-lactamase isolated from a child with leukemia

Toshiya Ohkawa; Masao Yoshinaga; Naoaki Ikarimoto; Hiroaki Miyanohara; Koichiro Miyata; Yohei Doi; Naohiro Shibata; Yoshichika Arakawa

An 8-year-old girl with acute leukemia had bacteremia caused by Klebsiella pneumoniae producing CTX-M-2-type broad spectrum beta-lactamase. K. pneumoniae and Escherichia coli strains producing the same enzyme and harboring identical conjugative plasmids were recovered from stoor culture. Patients with frequent episodes of neutropenia and prophylactic administration of beta-lactams are at risk of harboring colonizing strains that produce broad spectrum beta-lactamases.


Journal of Dermatology | 2013

Antimicrobial effect of an ultrasonic levitation washer disinfector with silver electrolysis and ozone oxidation on methicillin-resistant Staphylococcus aureus

Mariko Tamai; Shigeto Matsushita; Hiroaki Miyanohara; Naoko Imuta; Ryuji Ikeda; Kazuhiro Kawai; Junichiro Nishi; Akihiro Sakamoto; Takanori Shigihara; Takuro Kanekura

Methicillin‐resistant Staphylococcus aureus (MRSA) has rapidly emerged as a cause of severe and intractable skin infection. At present, there are no effective topical treatments, and infection or colonization by MRSA of the skin raises serious medical problems. We developed an ultrasonic levitation washer that generates silver ions (Ag+) and ozone (O3) to clean and sterilize medical devices. We report the effect of ultrasonic levitation (levitation) with Ag+ and O3 on MRSA in vitro and in vivo. Antimicrobial effect against six MRSA strains of all agr types was examined under three in vitro conditions; cells floating in a water tank, cells infiltrating‐, and cells forming a biofilm on an atelocollagen membrane. In the in vivo studies, we assayed the number of MRSA organisms that survived treatment on murine skin ulcers and evaluated the ulcer size. Levitation with Ag+ dramatically decreased the survival of MRSA floating in a water tank. Levitation with Ag+ and O3 significantly decreased the viability of MRSA that had infiltrated or formed a biofilm on atelocollagen membranes regardless of the level of biofilm production. In vivo studies showed that the number of MRSA on murine skin ulcers was significantly decreased when 15‐min treatment was performed for 7 consecutive days and that the ulcer size was significantly decreased after the seventh treatment course. Levitation with Ag+ and O3 may be a valuable tool for treating MRSA infestation of the skin and for accelerating wound healing.


The Journal of the Japanese Association for Infectious Diseases | 1999

The incidences of virulence genes in Escherichia coli strains from sporadic diarrheal children

Junichiro Nishi; Masao Yoshinaga; Kunihiro Manago; Hisatomo Kuroki; Akira Kamenosono; Akihiko Mogi; Hiroaki Miyanohara; Yasumitsu Baba; Takuya Ikeda; Koichiro Miyata


Journal of Infection and Chemotherapy | 2012

Reduction in the incidence of MRSA with use of alcohol-based hand rub solutions and gloves.

Kazuaki Matsumoto; Akari Shigemi; Keiko Yaji; Yoshihiro Shimodozono; Yasuo Takeda; Kazuro Ikawa; Norifumi Morikawa; Hiroaki Miyanohara; Hideki Kawamura; Michiyo Orita; Koichi Tokuda; Junichiro Nishi; Katsushi Yamada


Experimental and Therapeutic Medicine | 2011

1,5-Anhydro-D-fructose: A natural antibiotic that inhibits the growth of gram-positive bacteria and microbial biofilm formation to prevent nosocomial infection.

Xiaojie Meng; Ko-ichi Kawahara; Hiroaki Miyanohara; Yasushi Yoshimoto; Kazuhiro Yoshinaga; Satoshi Noma; Kiyoshi Kikuchi; Yoko Morimoto; Takashi Ito; Yoko Oyama; Narimasa Yoshinaga; Binita Shrestha; Binita Chandan; Kentaro Mera; Ko-ichi Tada; Naoki Miura; Yoshiko Ono; Kazunori Takenouchi; Ryuichi Maenosono; Tomoka Nagasato; Teruto Hashiguchi; Ikuro Maruyama

Collaboration


Dive into the Hiroaki Miyanohara's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge